semaglutide and vision loss linked to increased risk of in diabetes patients GLP-1 drugs and vision loss:
Description
Rapid weight loss without adequate fat intake concentrates bile and increases gallstone risk
Eventide was an injection-free GLP-1 agonist that showed promise, but ultimately didnt get FDA approval for its application to treat type 2 diabetes
The pattern of increasing receptor targets correlating with greater efficacy (and different dosing profiles) appears to be accelerating
Can you freeze peptides after reconstitution
pmid:32125483 32
